Physician

Peter Clark, M.D.

According to 2025 Medicare claims, Peter Clark, M.D. (NPI: 1548616485) practices ophthalmology in the Wenatchee-East Wenatchee, WA market, with the plurality of this provider's patient population coming from Douglas, WA. This provider's primary affiliated billing organization is CENTRAL WASHINGTON HEALTH SERVICES ASSOCIATION (NPI: 1881642239; TIN: 910171250) and primary practice location at 98801-3201. Clark is affiliated with the UC Irvine Health Accountable Care Organization (ACO ID: A3799) and CVS ACO (ACO ID: A5407), participating under the MSSP model.

Clark's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 538 traditional Medicare patients, billed 3,365 HCPCS/CPT codes, and received $186,867 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 252 prescription claims across 69 beneficiaries totaling $6,845 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 1 records totaling $5,914. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,464 to $186,867. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $33,929 to $6,845. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$93K$187K2020 Medicare payment: $5,464 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $11,120 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $43,265 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $169,481 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $186,867 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201126$5,464
20215987$11,120
2022205638$43,265
20235072,956$169,481
20245383,365$186,867

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$47K$94K2020 Drug cost: $33,929 (USD; Tot_Drug_Cst)2021 Drug cost: $94,166 (USD; Tot_Drug_Cst)2022 Drug cost: $16,270 (USD; Tot_Drug_Cst)2023 Drug cost: $7,322 (USD; Tot_Drug_Cst)2024 Drug cost: $6,845 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020107261$33,929
2021145415$94,166
202250107$16,270
202368210$7,322
202469252$6,845

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye179695$73
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more174211$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more227328$48
92134Imaging of retina5031,347$17
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's170238$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate361,168$1,238
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat724,349$1,042
RifampinRifampin13450$752
Brimonidine TartrateBrimonidine Tartrate19548$571
Ketorolac TromethamineKetorolac Tromethamine24592$402

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$5,914Carl Zeiss Meditec Digital Innovations LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Peter Clark, M.D.?

Tedicare shows public-source Medicare data for Peter Clark, M.D. (NPI 1548616485), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter Clark, M.D. have ACO affiliation data?

Peter Clark, M.D. is shown with ACO affiliation data for UC Irvine Health Accountable Care Organization (MSSP, ACO ID A3799) and CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Peter Clark, M.D.?

Peter Clark, M.D. is linked to CENTRAL WASHINGTON HEALTH SERVICES ASSOCIATION (billing NPI 1881642239) in the available physician profile data.

Does Peter Clark, M.D. have Open Payments data?

Peter Clark, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.